West Pharmaceutical Services, Inc. (WST) on Decifer

Why it ranks here

• It earns solid returns on the money it puts to work, around 14% and it turns most of its profit into real cash.
• Revenue is growing about 6% a year, profits grew 1% over the past year, and growth is speeding up, not slowing down.
• It keeps a healthy share of every sale as profit, and that has stayed steady over the years, a sign of real pricing power.
• It is riding an active market tailwind and has the balance sheet to fund its growth.
• It is not watering down its owners with new shares and it returns cash to shareholders.

The current read

The evidence on WST lines up on the supportive side: a live market force supports this name through its theme connection. The independent signals we track are telling the same story.

Read the full WST research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.